BrainStorm Cell Therapeutics, Inc. (BCLI.OB) Enters Agreement for Adult Stem Cell Production
Source: http://Blog.QualityStocks.net/?p=17521Posted on Monday, August 31st, 2009 | In Small & Micro Cap
BrainStorm Cell Therapeutics Inc. is a company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The technology allows for the differentiation of bone marrow-derived stem cells into functional neurons and astrocytes.
BrainStorm Cell Therapeutics is currently focusing its technology on two diseases – Parkinson’s and ALS, which is also known as Lou Gehrig’s disease. The company announced today that it has entered into an agreement with Protein Production Services Ltd., a leading manufacturing contractor, in order to start “good manufacturing practice” production of its stem cell therapeutic product.
The clinical-grade product will be used in a pre-clinical safety trial for the company’s innovative therapy for Lou Gehrig’s disease. BrainStorm’s proprietary adult stem cell technologies have already been successfully tested on various animal models of neurodegenerative diseases. Neuro-protective and neuro-regenerative applications of the technology have been published in more than a dozen peer-reviewed scientific journals.
Rami Efrati, CEO of BrainStorm Cell Therapeutics, said, “We are very excited that we are moving into this phase of product development with a highly-experienced contractor that will enable us to move rapidly ahead with the final stage of our ALS pre-clinical program.”
Mr. Efrati added, “As we announced on August 24 after securing new funding, BrainStorm now has both the financing and the production capabilities to achieve our goal of reaching human clinical studies in the coming year.”
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Omnicity Corp. (OMCY.OB) Announces Addition of New Board Member - November 20th, 2009
- Muscle Flex, Inc. (MFLI.PK) Announces Release Time for the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page - November 20th, 2009
- Artfest International, Inc. (ARTS.OB) Announces Revenue Profit Jumps - November 20th, 2009
- Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update - November 20th, 2009
- Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare - November 20th, 2009
adult stem cell, adult stem cell technologies, ALS, BrainStorm Cell Therapeutics, Brainstorm Cell Therapeutics Inc.;, ceo, clinical-grade product, company developing adult stem cell therapeutic products, contractor, innovative therapy, leading manufacturing contractor, Lou Gehrig, manufacturing contractor, neuro-regenerative applications, neurodegenerative diseases, Protein Production Services Ltd., Rami Efrati, Small & Micro Cap, stem cell therapeutic product, Stem Cells, therapy for Lou Gehrig’s disease, treatment of neurodegenerative diseases
 About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.